Status:
RECRUITING
Digital Health Technology for People With Mitochondrial Disease
Lead Sponsor:
Neuroscience Research Australia
Conditions:
Mitochondrial Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Abstract: A lack of exercise combined with low levels of activity is prominent in people with Mitochondrial Disease (MD). Unfortunately, access to health professionals such as physiotherapists with ex...
Detailed Description
Feasibility study Baseline measurements taken at: week 0 = pre-intervention, Outcome measurements taken at: week 9 = post-intervention assessment Feasibility outcomes: 1. the percentage of particip...
Eligibility Criteria
Inclusion
- ≥18 years of age
- Have a confirmed diagnosis of a PMD
- Be able to walk a minimum of 6 minutes with or without rest
- Provide written informed consent and
- Willingness and ability to comply with the study procedures
- Own a smart phone and be willing to download 2 apps
- internet access/telehealth app
Exclusion
- Have atrial fibrillation or untreated symptomatic cardiac arrhythmia
- Non-English speaking
- Are pregnant
- Are wheelchair bound
- Have visual acuity less than 6/60 (Snellen Test)
- Other co-morbidities such as severe osteoarthritis, balance impairment, chronic obstructive pulmonary disease, cognitive impairment, depression and anything else that would impact on participant adherence, participant safety or interpretation of results.
Key Trial Info
Start Date :
September 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2025
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT06535646
Start Date
September 9 2024
End Date
February 28 2025
Last Update
November 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuroscience Research Australia
Sydney, New South Wales, Australia, 2031